Previous 10 | Next 10 |
LANNETT ANNOUNCES FDA COMPLETES REVIEW OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BIOSIMILAR INSULIN GLARGINE --FDA States Pivotal Clinical Trial May Proceed, Trial Expected to Commence By March 2022-- PR Newswire PHILADELPHIA , Jan. 21, 2022 /PRNewswi...
LANNETT ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BIOSIMILAR INSULIN GLARGINE --Company Anticipates Commencing Pivotal Clinical Trial in March 2022-- PR Newswire PHILADELPHIA , Dec. 20, 2021 /PRNewswire/ -- Lannett Company, Inc. (...
Lannett Company, Inc. (LCI) Q1 2022 Earnings Conference Call November 3, 2021 04:30 PM ET Company Participants Robert Jaffe - Investor Relations Tim Crew - Chief Executive Officer John Kozlowski - Chief Financial Officer Conference Call Participants Scott Henry - ROTH Capital Partners, LLC Pr...
Image source: The Motley Fool. Lannett Company, inc (NYSE: LCI) Q1 2022 Earnings Call Nov 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lannett Company, inc (LCI) Q1 2022 Earnings Call Transcript
Lannett (NYSE:LCI): Q1 Non-GAAP EPS of -$0.27 misses by $0.03; GAAP EPS of -$0.56 misses by $0.28. Revenue of $101.5M (-19.8% Y/Y) beats by $2.88M. Press Release For further details see: Lannett EPS misses by $0.03, beats on revenue
Lannett Reports Fiscal 2022 First-Quarter Financial Results; Revises Down Full-year Guidance --Company Announces Restructuring Plan Targeting $20 Million in Reduced Expenses, To Consolidate Manufacturing Operations and Restructure the R&D Function-- - Q1 Business and Fin...
Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference Call On Wednesday, November 3 PR Newswire PHILADELPHIA , Oct. 28, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its f...
Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension PR Newswire PHILADELPHIA , Aug. 30, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing Mycophenolate Mofetil for Oral Suspension USP, 200 mg/...
Image source: The Motley Fool. Lannett Company, inc (NYSE: LCI) Q4 2021 Earnings Call Aug 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lannett Company, inc (LCI) Q4 2021 Earnings Call Transcript
Lannett Company, Inc. (LCI) Q4 2021 Earnings Conference Call August 25, 2021, 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Tim Crew - Chief Executive Officer John Kozlowski - Chief Financial Officer Maureen Cavanaugh - Chief Commercial Operations Officer Steve Lehrer - Le...
News, Short Squeeze, Breakout and More Instantly...
Lannett Co Inc Company Name:
LCI Stock Symbol:
NYSE Market:
NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS PR Newswire Company Expects No Impact on Operations Negotiations with Key Secured Creditors Progressing Toward a Balance Sheet Strengthening Transaction ...
LANNETT SHARES UPDATE PR Newswire Announces Positive Results from Pivotal Clinical Insulin Trial that Demonstrates Biosimilarity to Reference Product Productive Conversations with Key Secured Creditors Toward a Balance Sheet Strengthening, Recapitalization or Res...